NHS doctors improving healthcare for diabetic patients with VR medical training
NHS doctors are currently using virtual reality training to be better prepared for real-life emergencies for people suffering with Type 1 diabetes
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn MoreNHS doctors are currently using virtual reality training to be better prepared for real-life emergencies for people suffering with Type 1 diabetes
One Drop, a leader in the development of digital therapeutics solutions for people with diabetes and related conditions, today announced a partnership with Amazon's exclusive health brand, Choice.
ForaCare, Inc. US this week announced the launch of its FOR A GTel Multi-Functional Monitoring System with built-in cellular connectivity.
With its brain-activity monitoring tools, sleep science company Dreem is solving sleep-related problems of chronic insomnia affecting 10% of the worlds population, which World Sleep Day is addressing today
Nemaura Medical, a medical technology company focused on the development of SugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, has signed an exclusive license and supply agreement for SugarBEAT with TPMENA in the Gulf Cooperation Council (GCC) Region, which includes Bahrain, Kuwait, Saudi Arabia, Oman and United Arab Emirates.
Tandem Diabetes Care, an insulin delivery and diabetes technology company, announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario, Canada.
Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly identified during the ongoing DCLP3 phase of the International Diabetes Closed Loop (IDCL) clinical trial.
Healthagen, an Aetna business unit within CVS Health, and Welldoc, in collaboration with LifeScan, announced details of a study to evaluate the use and potential health benefits of OneTouch Reveal Plus.
Senseonics Holdings, a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced the integration of Eversense CGM data into the Glooko diabetes data management platform.
The first human study of a pill designed to replace injections of biologics is today being announced by Rani Therapeutics, the inventor of the RaniPill capsule.